MediciNova
MNOV
53 hedge funds and large institutions have $96.5M invested in MediciNova in 2018 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 24 increasing their positions, 12 reducing their positions, and 4 closing their positions.
6,000% more call options, than puts
Call options by funds: $122K | Put options by funds: $2K
175% more first-time investments, than exits
New positions opened: 11 | Existing positions closed: 4
100% more repeat investments, than reductions
Existing positions increased: 24 | Existing positions reduced: 12
94% more capital invested
Capital invested by funds: $49.7M → $96.5M (+$46.7M)
15% more funds holding
Funds holding: 46 → 53 (+7)
1.75% more ownership
Funds ownership: 21.3% → 23.05% (+1.7%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
+$6.29M |
| 2 |
BlackRock
New York
|
+$4.4M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$2.3M |
| 4 |
WC
Wexford Capital
West Palm Beach,
Florida
|
+$1.25M |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$1.06M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$3.81M |
| 2 |
TEE
Tibra Equities Europe
London,
United Kingdom
|
-$219K |
| 3 |
PP
Paloma Partners
Greenwich,
Connecticut
|
-$198K |
| 4 |
Renaissance Technologies
New York
|
-$142K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$126K |
MNOV Hedge Fund Activity: Q1 2018 in Review
53 of the 4,364 institutional investors tracked by Wall St. Rank reported a position in MediciNova (MNOV) for Q1 2018, worth a combined $96.5M — up 94% from $49.7M a quarter earlier.
Buyers outnumbered sellers: 11 funds opened new MNOV positions and 4 closed out — a net gain of 7 holders — while 24 added to existing stakes and 12 trimmed.
The largest buyer was Sphera Funds Management, opening a new position worth an estimated $6.29M. The largest seller was Fidelity Investments, cutting an estimated $3.81M.
- 53 institutional investors held MediciNova (MNOV) as of Q1 2018, up from 46 in Q4 2017.
- Funds reported $96.5M of MediciNova stock for Q1 2018, up 94% quarter-over-quarter.
- 11 funds opened new MediciNova positions in Q1 2018 and 4 closed out, a net change of +7 holders.
- The largest MediciNova buyer in Q1 2018 was Sphera Funds Management, an estimated $6.29M added.
- The largest MediciNova seller in Q1 2018 was Fidelity Investments, an estimated $3.81M sold.
Based on aggregated 13F filings for Q1 2018.